U.S. Government Intervenes in Power Wheelchair False Claims Case Against Orbit Medical Inc.
Power wheelchair claims are one of the most costly medical device codes submitted to Medicare and Medicaid each year. So much so, that the Office of Inspector General conducted a study in 2001 to determine whether these chairs are actually “medically necessary” in most cases and, if so, whether a […]
Tennessee Substance Abuse Facility New Life Lodge Settles Allegations of Medicaid Fraud
In a recent settlement out of Tennessee, California-based CRC Health Group, Inc. has agreed to pay $9.25 million to settle allegations of Medicaid fraud involving one of its addiction treatment centers located in the city of Burns. The settlement is the result of a joint investigation by the Tennessee Attorney […]
Doctor Settles Allegations of Performing Unnecessary Nasal Surgery on Pediatric Medicaid Patients
In yet another healthcare fraud case, an Oklahoma-based hospital, its parent company Health Management Associates, and Dr. Daniel Castro have agreed to settle a whistleblower lawsuit filed under the federal False Claims Act and its Oklahoma counterpart. According to the allegations found in the complaint, the medical professionals involved were […]
Hope Center Institute Submits False Claims to Federal Government, Settles for $2.9 Million
The Kansas-based cancer center known as Hope Cancer Institute and one of its physicians recently settled with the U.S. government over allegations of fraudulent billing practices. In the healthcare industry alone, the False Claims Act has been pivotal in recovering billions of dollars on behalf of American taxpayers. In fact, […]
Pfizer Unsuccessful in Avoiding Off-Label Marketing False Claims Act Case
In a recent False Claims Act case involving the mental health drug Geodon, Pfizer reportedly lost its bid to have the case dismissed after unsuccessfully arguing, among other claims, that relators failed the “first-to-file” and “public disclosure” requirements contained within the language of the FCA. Specifically, the FCA precludes whistleblowers […]